Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
7.35
+0.47 (6.83%)
At close: Jun 18, 2026, 4:00 PM EDT
7.66
+0.31 (4.22%)
After-hours: Jun 18, 2026, 7:59 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $65.31 million as of June 18, 2026. Its market cap has increased by 376.92% in one year.
Market Cap
65.31M
Enterprise Value
54.42M
1-Year Change
376.92%
Ranking
Category
Stock Price
$7.35
Market Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has increased from $37.12M to $65.31M, an increase of 75.95%. That is a compound annual growth rate of 8.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 65.31M | 451.88% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 59.75M |
| Filana Therapeutics | 58.94M |
| Impact BioMedical | 58.84M |
| MiNK Therapeutics | 58.84M |
| KALA BIO | 58.37M |
| Entera Bio | 58.09M |
| Seres Therapeutics | 57.81M |
| PMV Pharmaceuticals | 57.60M |